Shanghai Fosun Pharmaceutical (Group) Co., Ltd.:企業のM&A・事業提携・投資動向

◆英語タイトル:Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2119
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:101
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Shanghai Fosun Pharmaceutical (Group) Co., Ltd.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 36
Corporate Venturing – Overview 36
Corporate Venturing – Deal reports 37
PARTNERSHIP 49
Partnership – Overview 49
Partnership – Deal reports 50
CAPITAL RAISING 69
Capital Raising – Overview 69
Capital Raising – Deal reports 70
DIVESTMENTS 79
Divestments – Overview 79
Divestments – Deal reports 80
APPENDIX 90
Contact Us 90
About MarketLine Financial Deals Database 90
Deal Definition and Methodology 92
About MarketLine 99

List of Tables
Table 1: Shanghai Fosun Pharmaceutical (Group) Co. M&A volume and value trend (2014-YTD2018)
Table 2: Shanghai Fosun Pharmaceutical (Group) Co. M&A activity by geography (2014-YTD2018)
Table 3: Shanghai Fosun Pharmaceutical (Group) Co. corporate venturing volume and value trend (2014-YTD2018)
Table 4: Shanghai Fosun Pharmaceutical (Group) Co. corporate venturing by geography (2014-YTD2018)
Table 5: Shanghai Fosun Pharmaceutical (Group) Co. partnership volume and value trend (2014-YTD2018)
Table 6: Shanghai Fosun Pharmaceutical (Group) Co. partnership trend by key deal type (2014-YTD2018)
Table 7: Shanghai Fosun Pharmaceutical (Group) Co. capital raising volume and value trend (2014-YTD2018)
Table 8: Shanghai Fosun Pharmaceutical (Group) Co. capital raising by deal type (2014-YTD2018)
Table 9: Shanghai Fosun Pharmaceutical (Group) Co. divestments volume and value trend (2014-YTD2018)
Table 10: Shanghai Fosun Pharmaceutical (Group) Co. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Shanghai Fosun Pharmaceutical (Group) Co. M&A volume and value trend (2014-YTD2018)
Figure 2: Shanghai Fosun Pharmaceutical (Group) Co. M&A activity by geography (2014-YTD2018)
Figure 3: Shanghai Fosun Pharmaceutical (Group) Co. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Shanghai Fosun Pharmaceutical (Group) Co. corporate venturing by geography (2014-YTD2018)
Figure 5: Shanghai Fosun Pharmaceutical (Group) Co. partnership volume and value trend (2014-YTD2018)
Figure 6: Shanghai Fosun Pharmaceutical (Group) Co. partnership trend by key deal type (2014-YTD2018)
Figure 7: Shanghai Fosun Pharmaceutical (Group) Co. capital raising volume and value trend (2014-YTD2018)
Figure 8: Shanghai Fosun Pharmaceutical (Group) Co. capital raising by deal type (2014-YTD2018)
Figure 9: Shanghai Fosun Pharmaceutical (Group) Co. divestments volume and value trend (2014-YTD2018)
Figure 10: Shanghai Fosun Pharmaceutical (Group) Co. divestments by geography (2014-YTD2018)

★海外企業調査レポート[Shanghai Fosun Pharmaceutical (Group) Co., Ltd.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Luminex Corp (LMNX)-製薬・医療分野:企業M&A・提携分析
    Summary Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technol …
  • H-E-B Grocery Company L.P.:企業の戦略・SWOT・財務情報
    H-E-B Grocery Company L.P. - Strategy, SWOT and Corporate Finance Report Summary H-E-B Grocery Company L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Compagnie de Saint-Gobain:企業のM&A・事業提携・投資動向
    Compagnie de Saint-Gobain - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Compagnie de Saint-Gobain Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Vitruvian Exploration II LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Vitruvian Exploration II LLC (Vitruvian Exploration II) is an oil and gas company that provides exploration and development of oil properties. The company provides exploration of onshore North American unconventional oil and gas resource plays. Its VEX II Woodford Apollo project has various …
  • PZ Cussons Nigeria Plc:企業の戦略・SWOT・財務分析
    PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report Summary PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Moneysupermarket.com Group PLC (MONY):企業の財務・戦略的SWOT分析
    Moneysupermarket.com Group PLC (MONY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Farbest-Tallman Foods Corp.:企業の戦略・SWOT・財務情報
    Farbest-Tallman Foods Corp. - Strategy, SWOT and Corporate Finance Report Summary Farbest-Tallman Foods Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Phoenix Pharmahandel GmbH & Co KG:企業の戦略的SWOT分析
    Phoenix Pharmahandel GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Kering SA:戦略・SWOT・企業財務分析
    Kering SA - Strategy, SWOT and Corporate Finance Report Summary Kering SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Bureau Veritas SA (BVI)-エネルギー分野:企業M&A・提携分析
    Summary Bureau Veritas SA (Bureau Veritas) is a testing, inspection and certification service provider that offers varied services such as asset management, certification, classification, consulting, inspection and audits, testing and analysis, and training. The company serves aeronautics, agricultu …
  • Yamana Gold Inc.
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cosmo Oil Co., Ltd.:企業の戦略・SWOT・財務分析
    Cosmo Oil Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cosmo Oil Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • The Walter and Eliza Hall Institute of Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary The Walter and Eliza Hall Institute of Medical Research (WEHI), a subsidiary of Melbourne Medical School The University of Melbourne is a medical research institute that conducts clinical research, and offers educational and contract research services. The institute develops therapeutics for …
  • Onex Corporation:企業の戦略・SWOT・財務情報
    Onex Corporation - Strategy, SWOT and Corporate Finance Report Summary Onex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sinovac Biotech Ltd (SVA):企業の財務・戦略的SWOT分析
    Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, bilive, anflu, panflu and panflu, among others. Its healive is an inactivated hepatitis A vaccine. Sinovac Biotech’s bilive i …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • INTL FCStone Inc:戦略・SWOT・企業財務分析
    INTL FCStone Inc - Strategy, SWOT and Corporate Finance Report Summary INTL FCStone Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Episurf Medical AB (EPIS B):企業の製品パイプライン分析2018
    Summary Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. The company offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, E …
  • Prism Medical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Prism Medical Ltd (Prism Medical), a subsidiary of Handicare AB is a medical device company that manufacturer and provides durable medical equipment. The company offers products such as fixed ceiling lifts, portable ceiling lifts, portable track systems, mobile floor lifts, sling systems, ho …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆